Sheen Victoria, Bhalla Vikas, Tulua-Tata Alisi, Bhalla Meenakshi A, Weiss Danielle, Chiu Albert, Abdeen Omaran, Mullaney Scott, Maisel Alan
Division of Cardiology, the Department of Medicine, Veteran's Affairs Medical Center and University of California, San Diego, CA 92161, USA.
Am Heart J. 2007 Feb;153(2):244.e1-5. doi: 10.1016/j.ahj.2006.10.041.
Although B-type natriuretic peptide (BNP) levels correlate with volume overload in congestive heart failure, its usefulness in patients with renal dysfunction has been questioned. A simple test to estimate volume overload and assist in the management of dry weight in hemodialysis (HD) patients would be useful.
Thirty-nine patients--aged 64 +/- 2 years (mean +/- SEM), male-female ratio of 37:2--undergoing HD thrice weekly for at least 30 days were studied. Samples were collected at the start and end of each of 3 consecutive HD sessions. Pre- and postsession weights and blood pressures were recorded. Left ventricular ejection fractions were obtained from echocardiograms performed within 1 year of enrollment. The first session was the dialysis session after a 72-hour interdialytic period, whereas the second and third sessions were after a 48-hour period. Plasma volume changes were measured in a subset of 13 patients.
Pre- and postdialysis BNP levels for each of the 3 sessions were 434 and 343 pg/mL, 347 and 231 pg/mL, and 249 and 202 pg/mL, respectively. The values for body weights were 82.6 +/- 3.6 and 78.6 +/- 3.5 kg, 81.5 +/- 3.6 and 78.2 +/- 3.5 kg, and 81.5 +/- 3.46 and 78.3 +/- 3.5 kg, respectively. The values of mean systolic blood pressures were 150 +/- 4 and 134 +/- 3 mm Hg, 142 +/- 4 and 134 +/- 4 mm Hg, and 142 +/- 4 and 131 +/- 4 mm Hg, respectively. The values for mean diastolic blood pressures were 81 +/- 2.5 and 70 +/- 2.4 mm Hg, 74 +/- 2.4 and 72.1 +/- 2.2 mm Hg, and 76 +/- 2.9 and 72 +/- 2.9 mm Hg, respectively. There was no correlation between changes in intradialytic BNP values and other measured parameters. Plasma volume changed minimally during dialysis.
Values of BNP are elevated in patients with end-stage renal disease and decline after each dialysis session. Over the course of a week, BNP levels gradually declined irrespective of changes in weight or blood pressure. The lack of correlation between changes in BNP and changes in measured clinical parameters is partly explained by a lack of a significant change in plasma volume. The highest BNP values were seen in patients with systolic dysfunction.
尽管B型利钠肽(BNP)水平与充血性心力衰竭中的容量超负荷相关,但其在肾功能不全患者中的实用性受到质疑。一项用于评估容量超负荷并辅助管理血液透析(HD)患者干体重的简单测试将很有用。
对39例年龄为64±2岁(平均±标准误)、男女比例为37:2、每周进行3次HD至少30天的患者进行研究。在连续3次HD治疗的每次治疗开始和结束时采集样本。记录治疗前后的体重和血压。从入组后1年内进行的超声心动图检查中获取左心室射血分数。第一次治疗是在72小时透析间期后的透析治疗,而第二次和第三次治疗是在48小时透析间期后的透析治疗。在13例患者的亚组中测量血浆容量变化。
3次治疗每次透析前和透析后的BNP水平分别为434和343 pg/mL、347和231 pg/mL、249和202 pg/mL。体重值分别为82.6±3.6和78.6±3.5 kg、81.5±3.6和78.2±3.5 kg、81.5±3.46和78.3±3.5 kg。平均收缩压值分别为150±4和134±3 mmHg、142±4和134±4 mmHg、142±4和131±4 mmHg。平均舒张压值分别为81±2.5和70±2.4 mmHg、74±2.4和72.1±2.2 mmHg、76±2.9和72±2.9 mmHg。透析期间BNP值的变化与其他测量参数之间无相关性。透析期间血浆容量变化极小。
终末期肾病患者的BNP值升高,每次透析治疗后下降。在一周的过程中,无论体重或血压如何变化,BNP水平逐渐下降。BNP变化与测量的临床参数变化之间缺乏相关性,部分原因是血浆容量没有显著变化。收缩功能不全患者的BNP值最高。